Table 1.
Characteristic | Active acupuncture (n=11) | Sham acupuncture (n=10) |
---|---|---|
Age±SD | 50.8±10.6 | 50±9.9 |
ECOG performance status | ||
0 | 3 | 0 |
1 | 8 | 7 |
New diagnosis | 4 (19%) | 5 (23.8%) |
Recurrent disease | 7 (33.3%) | 5 (23.8%) |
# (%) of patients receiving specific drug treatment | ||
Carboplatin/paclitaxel | 6 (28.6%) | 5 (23.8%) |
Gemcitabine | 3 (14.3%) | 3 (14.3%) |
Topotecan | 1 (4.8%) | 2 (9.5%) |
Vinorelbine | 1 (4.8%) | 0 (0%) |
SD, standard deviation; ECOG, Eastern Cooperative Oncology Group.